Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placenta

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Szukiewicz, Dariusz ^a   Kochanowski, Jan ^a   Pyzlak, Michal ^a   Szewczyk, Grzegorz ^a   Stangret, Aleksandra ^a   Mittal, Tarun Kumar ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, HUMAN; CX3CR1 PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ARTICLE; DIABETES MELLITUS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE HOMOGENATE; COMPARATIVE STUDY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MICROCIRCULATION; NEOVASCULARIZATION (PATHOLOGY); PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; SIGNAL TRANSDUCTION; VASCULARIZATION; YOUNG ADULT;

ADULT; CHEMOKINE CX3CL1; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84881438524     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/437576     Document Type: Article

References (53)

1. Kumpel B. M., Manoussaka M. S., Placental immunology and maternal alloimmune responses. Vox Sanguinis 2012 102 1 2 12 2-s2.0-84655169213 10.1111/j.1423-0410.2011.01533.x
2. Hauguel-de Mouzon S., Guerre-Millo M., The placenta cytokine network and inflammatory signals. Placenta 2006 27 8 794 798 2-s2.0-33745470336 10.1016/j.placenta.2005.08.009 (Pubitemid 43947814)
3. Park D. W., Yang K. M., Hormonal regulation of uterine chemokines and immune cells. Clinical and Experimental Reproductive Medicine 2011 38 4 179 185
4. Ribatti D., Crivellato E., Immune cells and angiogenesis. Journal of Cellular and Molecular Medicine 2009 13 9 2822 2833 2-s2.0-72849141569 10.1111/j.1582-4934.2009.00810.x
5. Daskalakis G., Marinopoulos S., Krielesi V., Papapanagiotou A., Papantoniou N., Mesogitis S., Antsaklis A., Placental pathology in women with gestational diabetes. Acta Obstetricia et Gynecologica Scandinavica 2008 87 4 403 407 2-s2.0-41649105070 10.1080/00016340801908783 (Pubitemid 351481707)
6. Leach L., Taylor A., Sciota F., Vascular dysfunction in the diabetic placenta: causes and consequences. Journal of Anatomy 2009 215 1 69 76 2-s2.0-67449137959 10.1111/j.1469-7580.2009.01098.x
7. Jawerbaum A., González E., Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Current Medicinal Chemistry 2006 13 18 2127 2138 2-s2.0-33746538871 10.2174/092986706777935302 (Pubitemid 44132605)
8. Desoye G., Hauguel-De Mouzon S., The human placenta in gestational diabetes mellitus: the insulin and cytokine network. Diabetes Care 2007 30 2 S120 S126 2-s2.0-34447118714 10.2337/dc07-s203 (Pubitemid 47036413)
9. White P., Classification of obstetric diabetes. American Journal of Obstetrics and Gynecology 1978 130 2 228 230 2-s2.0-0017800739 (Pubitemid 8286328)
10. Szukiewicz D., Szukiewicz A., Maslinska D., Markowski M. W., Placental mast cells (MC) and histamine (HA) in pregnancy complicated by diabetes class C-relation to the development of villous microvessels. Placenta 1999 20 supplement 1 503 510
11. Szukiewicz D., Szukiewicz A., Maslinska D., Szewczyk G., Watroba M., Mast cell-derived vascular endothelial growth factor (VEGF) and microvascular density in diabetic placentae. Inflammation Research 2003 52 1 S09 S10 2-s2.0-0037391615 (Pubitemid 36470035)
12. Norrby K., Mast cells and angiogenesis: review article. APMIS 2002 110 5 355 371 2-s2.0-0036085728 10.1034/j.1600-0463.2002.100501.x (Pubitemid 34666551)
13. Zeng J., Xie K., Wu H., Zhang B., Huang C., Identification and functional study of cytokines and chemokines involved in tumorigenesis. Combinatorial Chemistry and High Throughput Screening 2012 15 3 276 285 2-s2.0-84858205956 10.2174/138620712799218608
14. Zlotnik A., Yoshie O., The chemokine superfamily revisited. Immunity 2012 36 5 705 716
15. 3C motif. Nature 1997 385 6617 640 644 2-s2.0-0031036347 10.1038/385640a0 (Pubitemid 27087578)
16. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J.-A., Vath J., Gossellin M., Ma J., Dussault B., Woolf E., Alperin G., Culpepper J., Gutierrez-Ramos J. C., Gearing D., Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997 389 6646, article 100 2-s2.0-0030886812 10.1038/38048 (Pubitemid 27387700)
17. Nomiyama H., Imai T., Kusuda J., Miura R., Callen D. F., Yoshie O., Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenetics and Cell Genetics 1998 81 1 10 11 2-s2.0-0031849219 (Pubitemid 28380092)
18. Jones B. A., Beamer M., Ahmed S., Fractalkine/CX3CL1: a potential new target for inflammatory diseases. Molecular Interventions 2010 10 5 263 270 2-s2.0-78149492552 10.1124/mi.10.5.3
19. Dimitriadis E., Nie G., Hannan N. J., Paiva P., Salamonsen L. A., Local regulation of implantation at the human fetal-maternal interface. International Journal of Developmental Biology 2010 54 2-3 313 322 2-s2.0-77950346058 10.1387/ijdb.082772ed
20. Bowen J. M., Chamley L., Mitchell M. D., Keelan J. A., Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002 23 4 239 256 2-s2.0-0036549808 10.1053/plac.2001.0781 (Pubitemid 41348517)
21. Taki A., Abe M., Komaki M., Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenital Anomalies 2012 52 2 97 103
22. Shimoya K., Zhang Q., Tenma K., Ota Y., Hashimoto K., Shizusawa Y. Y., Kimura T., Koyama M., Murata Y., Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy. Molecular Human Reproduction 2003 9 2 97 101 2-s2.0-0037291299 10.1093/molehr/gag009 (Pubitemid 36285150)
23. Umehara H., Bloom E. T., Okazaki T., Nagano Y., Yoshie O., Imai T., Fractalkine in vascular biology: from basic research to clinical disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 34 40 2-s2.0-0347123001 10.1161/01.ATV.0000095360.62479.1F (Pubitemid 38082409)
24. Cartwright J. E., Keogh R. J., Patot M. C. T. V., Hypoxia and placental remodelling. Advances in Experimental Medicine and Biology 2007 618 113 126 2-s2.0-58249101108 10.1007/978-0-387-75434-5-9
25. 3C chemokine fractalkine. Blood 2011 118 22 e156 e167 2-s2.0-82155183271 10.1182/blood-2011-04-348946
26. Clark A. K., Staniland A. A., Malcangio M., Fractalkine/CX3CR1 signalling in chronic pain and inflammation. Current Pharmaceutical Biotechnology 2011 12 10 1707 1714 2-s2.0-80053478471
27. D'Haese J. G., Demir I. E., Friess H., Ceyhan G. O., Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opinion on Therapeutic Targets 2010 14 2 207 219 2-s2.0-74949104597 10.1517/14728220903540265
28. Imaizumi T., Yoshida H., Satoh K., Regulation of CX3CL1/fractalkine expression in endothelial cells. Journal of Atherosclerosis and Thrombosis 2004 11 1 15 21 2-s2.0-3042826352
29. Ryu J., Lee C.-W., Hong K.-H., Shin J.-A., Lim S.-H., Park C.-S., Shim J., Nam K. B., Choi K.-J., Kim Y.-H., Han K. H., Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovascular Research 2008 78 2 333 340 2-s2.0-42349095639 10.1093/cvr/cvm067 (Pubitemid 351556089)
30. Mehrad B., Keane M. P., Strieter R. M., Chemokines as mediators of angiogenesis. Thrombosis and Haemostasis 2007 97 5 755 762 2-s2.0-34249066312 10.1160/TH07-01-0040 (Pubitemid 46804315)
31. Szukiewicz D., Gujski M., Maslinska D., Szewczyk G., Bachanek M., Maslinski S., Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture-influence of hypoxia. Inflammation Research 2005 54 1 S82 S83 2-s2.0-21144442141 10.1007/s00011-004-0438-2 (Pubitemid 40880803)
32. Huppertz B., Abe E., Murthi P., Nagamatsu T., Szukiewicz D., Salafia C., Placental angiogenesis, maternal and fetal vessels-a workshop report. Placenta 2007 28 S94 S96 2-s2.0-33947725523 10.1016/j.placenta.2007.01.015 (Pubitemid 46506057)
33. Brown K. J., Maynes S. F., Bezos A., Maguire D. J., Ford M. D., Parish C. R., A novel in vitro assay for human angiogenesis. Laboratory Investigation 1996 75 4 539 555 2-s2.0-0029859044 (Pubitemid 26346804)
34. Reynolds L. P., Biondini M. E., Borowicz P. P., Vonnahme K. A., Caton J. S., Grazul-Bilska A. T., Redmer D. A., Functional significance of developmental changes in placental microvascular architecture: the sheep as a model. Endothelium 2005 12 1-2 11 19 2-s2.0-20844455944 10.1080/10623320590933734 (Pubitemid 40861884)
35. Mayhew T. M., Charnock-Jones D. S., Kaufmann P., Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004 25 2-3 127 139 2-s2.0-1342344900 10.1016/j.placenta. 2003.10.010 (Pubitemid 38258173)
36. Lappas M., Mittion A., Permezel M., In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. Journal of Endocrinology 2010 204 1 75 84. Erratum in: Journal of Endocrinology, vol. 204, no. 2, p. 221, 2010 2-s2.0-73949102011 10.1677/JOE-09-0321
37. Zhang J., Hu H., Palma N. L., Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion. American Journal of Physiology 2012 303 10 L912 L922
38. You J.-J., Yang C.-H., Huang J.-S., Chen M.-S., Yang C.-M., Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. Investigative Ophthalmology and Visual Science 2007 48 11 5290 5298 2-s2.0-38449111303 10.1167/iovs.07-0187 (Pubitemid 351260943)
39. Yamashita K., Imaizumi T., Hatakeyama M., Tamo W., Kimura D., Kumagai M., Yoshida H., Satoh K., Effect of hypoxia on the expression of fractalkine in human endothelial cells. Tohoku Journal of Experimental Medicine 2003 200 4 187 194 2-s2.0-0242609935 10.1620/tjem.200.187 (Pubitemid 37406932)
40. Lee S.-J., Namkoong S., Kim Y.-M., Kim C.-K., Lee H., Ha K.-S., Chung H.-T., Kwon Y.-G., Kim Y.-M., Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. American Journal of Physiology 2006 291 6 H2836 H2846 2-s2.0-33845467811 10.1152/ajpheart.00113. 2006 (Pubitemid 44904084)
41. Volin M. V., Woods J. M., Amin M. A., Connors M. A., Harlow L. A., Koch A. E., Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. American Journal of Pathology 2001 159 4 1521 1530 2-s2.0-0034790738 (Pubitemid 32947980)
42. Mizutani N., Sakurai T., Shibata T., Uchida K., Fujita J., Kawashima R., Kawamura Y. I., Toyama-Sorimachi N., Imai T., Dohi T., Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. Journal of Immunology 2007 179 11 7478 7487 2-s2.0-38849197936
43. Morimura S., Sugaya M., Sato S., Interaction between CX3CL1 and CX3CR1 Regulates Vasculitis Induced by Immune Complex Deposition. American Journal of Pathology 2013 182 5 1640 1647
44. Sciumé G., Soriani A., Piccoli M., Frati L., Santoni A., Bernardini G., CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1. Neuro-Oncology 2010 12 7 701 710 2-s2.0-78650290339 10.1093/neuonc/nop076
45. Chandrasekar B., Mummidi S., Perla R. P., Bysani S., Dulin N. O., Liu F., Melby P. C., Fractalkine (CX3CL1) stimulated by nuclear factor B (NF- B)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochemical Journal 2003 373 2 547 558 2-s2.0-0041845203 10.1042/BJ20030207 (Pubitemid 36897857)
46. Pustovrh M. C., Jawerbaum A., Capobianco E., White V., López-Costa J. J., González E., Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta 2005 26 4 339 348 2-s2.0-16844376538 10.1016/j.placenta.2004.06.011 (Pubitemid 40485871)
47. Kuc S., Wortelboer E. J., Koster M. P. H., De Valk H. W., Schielen P. C. J. I., Visser G. H. A., Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. An International Journal of Obstetrics and Gynaecology 2011 118 6 748 754 2-s2.0-79954479326 10.1111/j.1471-0528.2011.02904.x
48. Mitamura Y., Harada C., Harada T., Role of cytokines and trophic factors in the pathogenesis of diabetic retinopathy. Current Diabetes Reviews 2005 1 1 73 81 2-s2.0-34548326641 10.2174/1573399052952596
49. Durham J. T., Herman I. M., Microvascular modifications in diabetic retinopathy. Current Diabetes Reports 2011 11 4 253 264 2-s2.0-80051597186 10.1007/s11892-011-0204-0
50. Ito Y., Kawachi H., Morioka Y., Nakatsue T., Koike H., Ikezumi Y., Oyanagi A., Natori Y., Natori Y., Nakamura T., Gejyo F., Shimizu F., Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Kidney International 2002 61 6 2044 2057 2-s2.0-0036098871 10.1046/j.1523-1755.2002.00369.x (Pubitemid 34539322)
51. Szukiewicz D., Maslinska D., Poppe P., Gujski M., Tomecki A., Placental mast cell heterogeneity in pregnancy complicated by diabetes class C. Inflammation Research 2000 49 1 S33 S34 2-s2.0-0034023150 (Pubitemid 30262684)
52. Papadopoulos E. J., Fitzhugh D. J., Tkaczyk C., Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. European Journal of Immunology 2000 30 8 2355 2361
53. Carmeliet P., Jain R. K., Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nature Reviews Drug Discovery 2011 10 6 417 427 2-s2.0-79957894276 10.1038/nrd3455